Table 5.
Adverse conditions and severe complications in women with early-onset and late-onset preeclampsia.
| Organ system affected | EOP (n = 113) | LOP (n = 101) | p | |||
|---|---|---|---|---|---|---|
| Adverse conditions | Severe complications | Adverse conditions | Severe complications | Adverse conditions | Severe complications | |
| CNS, n (%) | 3 (2.6) | 17 (15.0) | 1 (1.0) | 7 (7.0) | ns | ns |
| Cardiorespiratory, n (%) | 2 (1.7) | 34 (30.0) | 1 (1.0) | 2 (2.0) | ns | <0.0001 |
| Hematological, n (%) | 37 (32.7) | 24 (21.2) | 29 (29.0) | 9 (9.0) | ns | 0.0127 |
| Renal, n (%) | 15 (13.2) | 2 (1.7) | 8 (8.0) | 1 (1.0) | ns | ns |
| Hepatic, n (%) | 15 (13.2) | 0 (0.0) | 8 (8.0) | 0 (0.0) | ns | ns |
| Fetoplacental, n (%) | 87 (77.0) | 21 (18.5) | 42 (42.0) | 3 (3.0) | <0.0001 | 0.0003 |
CNS, central nervous system; EOP, early-onset preeclampsia; LOP, late-onset preeclampsia; ns, nonstatistically significant.